Skip to content

Efficacy and Safety of Oxycodone Hydrochloride Combined with Cyclopropylphenol in Painless Gastrointestinal Endoscopy

Efficacy and Safety of Oxycodone Hydrochloride Combined with Cyclopropylphenol in Painless Gastrointestinal Endoscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600128567
Enrollment
Unknown
Registered
2026-07-22
Start date
2025-10-09
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal discomfort

Interventions

Part Two: Fentanyl combined with cyclopofol group:Fentanyl 1 µ g/kg+0.4mg/kg cyclopofol
Part Two: Oxycodone group combined with cyclopofol group:Oxycodone + cyclopofol: Part One Research Results
Part Two: Normal Saline group combined with cyclopofol group:2ml of normal saline +0.5mg/kg cyclopofol
Part one : 01 group:Oxycodone (0.05mg/kg) + cyclopofol (0.5mg/kg)
Part one : 02 group:Oxycodone (0.075mg/kg) + cyclopofol (0.4mg/kg)
Part one : 03 group:Oxycodone (0.1mg/kg) + cyclopofol (0.3mg/kg)

Sponsors

Peking University International Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age range: >=18 and20 and < 30.

Exclusion criteria

Exclusion criteria: 1.History of neurological disorders or mental illness; 2.History of anesthesia surgery within the past month; 3.Long-term use of analgesic drugs; 4.Uncontrolled hypertension, arrhythmia, and heart failure and other medical histories; 5. History of obstructive sleep apnea (OSA), acute upper respiratory tract infection, asthma and other respiratory diseases; 6.History of anesthetic drug allergy; 7. Long-term heavy drinking; 8.Coagulation dysfunction.

Design outcomes

Primary

MeasureTime frame
Incidence of intraoperative hypoxemia in patients;Body movement response;Coughing response;

Secondary

MeasureTime frame
Heart rate;Pulse oximetry;Modified observer’s assessment of alert;Blood pressure;degree of satisfaction;Total dosage of medication;Awakening time;Incidence of adverse reactions;

Countries

China

Contacts

Public ContactYao Lan

Peking University International Hospital

1507yaolan@sina.com+86 13671010819

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026